Champions Oncology (CSBR) director Mendelson bought 5,000 shares for $28.3K at $5.65
Insider transactions reported
Daniel Newman Mendelson (director at Champions Oncology Inc., CSBR) reported that they bought 5,000 shares for $28.3K at $5.65 on Sep 26, 2023. After these transactions the filing shows 145,951 shares held directly.
- Reporting person
- Mendelson Daniel Newman
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Sep 26, 2023 | Open-market purchase (P) | Common Stock | +5,000 | $5.65 | $28.3K | 145,951 direct |
Holdings before and after
- Common Stock: 140,951 to 145,951 direct
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Mendelson report in this CSBR Form 4?
Daniel Newman Mendelson (director at Champions Oncology Inc., CSBR) reported that they bought 5,000 shares for $28.3K at $5.65 on Sep 26, 2023. After these transactions the filing shows 145,951 shares held directly.
How many CSBR shares does Mendelson hold after this filing?
The filing shows 145,951 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for CSBR
Earlier insider filings at CSBR
- Sep 25, 2023SEC Form 4: Mendelson Daniel Newman bought $26,400 worth of shares (5,000 units at $5.28), increasing direct ownership by 4% to 128,121 units
- Sep 25, 2023SEC Form 4: Mendelson Daniel Newman bought $22,139 worth of shares (4,018 units at $5.51), increasing direct ownership by 3% to 132,139 units
- Sep 25, 2023SEC Form 4: Mendelson Daniel Newman bought $27,550 worth of shares (5,000 units at $5.51), increasing direct ownership by 4% to 137,139 units
- Sep 25, 2023SEC Form 4: Mendelson Daniel Newman bought $20,966 worth of shares (3,812 units at $5.50), increasing direct ownership by 3% to 140,951 units
- Aug 17, 2023SEC Form 4 filed by Ackerman Joel
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Follow CSBR and get a push notification the moment its next story breaks.